MYC and Miyoshi myopathy: As shown in Figure 1A,B, c-Myc inhibitor, which acts by interfering with c-Myc/Max interaction and thus preventing c-Myc target gene expression, reduced cell survival in a dose- and time-dependent fashion in all MM and PEL cell lines studied.